LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 4 of total 4

Search options

  1. Article: Antihypertensive drugs are associated with reduced fatal outcomes and improved clinical characteristics in elderly COVID-19 patients.

    Yan, Feifei / Huang, Fengming / Xu, Jun / Yang, Penghui / Qin, Yuhao / Lv, Jingjun / Zhang, Shaogeng / Ye, Lu / Gong, Ming / Liu, Zhibo / Wei, Jie / Xie, Tuxiu / Xu, Kai-Feng / Gao, George F / Wang, Fu-Sheng / Cai, Lin / Jiang, Chengyu

    Cell discovery

    2020  Volume 6, Issue 1, Page(s) 77

    Abstract: ... to patients who took no drugs. The reduction of disease severity of elderly COVID-19 patients was associated ... Our data indicate that hypertension drugs ARB, ACEI, CCB, and BB might be beneficial for COVID-19 patients. ... statistically significantly improved in patients who took antihypertension drugs ARB, BB, and CCB after ...

    Abstract The novel coronavirus (CoV) severe acute respiratory syndrome (SARS)-CoV-2 outbreak began at the end of 2019 in Wuhan, China, and has spread to over 200 countries. In this multicenter retrospective study, we identified 2190 adult patients admitted for laboratory-confirmed COVID-19 in three participating centers. Multivariate logistic regression was conducted in patients with comorbid hypertension to examine the potential association between clinical outcomes, disease severity, and clinical characteristics with the use of ACEI, ARB, calcium-channel blockers (CCB), beta-blockers (BB), and thiazide diuretics. The clinical outcome, dyspnea, and fatigue were significantly improved in patients, especially elderly patients who were older than 65 years, who took ARB drugs prior to hospitalization compared to patients who took no drugs. The reduction of disease severity of elderly COVID-19 patients was associated with CCB and ACEI users. Clinical indices, including CRP, lymphocyte count, procalcitonin D dimer, and hemoglobin, were significantly improved in elderly ARB users. In addition, the clinical outcomes were statistically significantly improved in patients who took antihypertension drugs ARB, BB, and CCB after statistical adjustment by all ages, gender, baseline of blood pressures, and coexisting medical conditions. Our data indicate that hypertension drugs ARB, ACEI, CCB, and BB might be beneficial for COVID-19 patients.
    Language English
    Publishing date 2020-10-29
    Publishing country England
    Document type Journal Article
    ISSN 2056-5968
    ISSN 2056-5968
    DOI 10.1038/s41421-020-00221-6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Antihypertensive drugs are associated with reduced fatal outcomes and improved clinical characteristics in elderly COVID-19 patients

    Yan, Feifei Huang Fengming Xu Jun Yang Penghui Qin Yuhao Lv Jingjun Zhang Shaogeng Ye Lu Gong Ming Liu Zhibo Wei Jie Xie Tuxiu Xu Kai-Feng Gao George F. / Wang, Fu-Sheng Cai Lin Jiang Chengyu

    Cell Discovery

    Abstract: ... to patients who took no drugs The reduction of disease severity of elderly COVID-19 patients was associated ... Our data indicate that hypertension drugs ARB, ACEI, CCB, and BB might be beneficial for COVID-19 patients ... statistically significantly improved in patients who took antihypertension drugs ARB, BB, and CCB after ...

    Abstract The novel coronavirus (CoV) severe acute respiratory syndrome (SARS)-CoV-2 outbreak began at the end of 2019 in Wuhan, China, and has spread to over 200 countries In this multicenter retrospective study, we identified 2190 adult patients admitted for laboratory-confirmed COVID-19 in three participating centers Multivariate logistic regression was conducted in patients with comorbid hypertension to examine the potential association between clinical outcomes, disease severity, and clinical characteristics with the use of ACEI, ARB, calcium-channel blockers (CCB), beta-blockers (BB), and thiazide diuretics The clinical outcome, dyspnea, and fatigue were significantly improved in patients, especially elderly patients who were older than 65 years, who took ARB drugs prior to hospitalization compared to patients who took no drugs The reduction of disease severity of elderly COVID-19 patients was associated with CCB and ACEI users Clinical indices, including CRP, lymphocyte count, procalcitonin D dimer, and hemoglobin, were significantly improved in elderly ARB users In addition, the clinical outcomes were statistically significantly improved in patients who took antihypertension drugs ARB, BB, and CCB after statistical adjustment by all ages, gender, baseline of blood pressures, and coexisting medical conditions Our data indicate that hypertension drugs ARB, ACEI, CCB, and BB might be beneficial for COVID-19 patients
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #894383
    Database COVID19

    Kategorien

  3. Article ; Online: Antihypertensive drugs are associated with reduced fatal outcomes and improved clinical characteristics in elderly COVID-19 patients

    Yan, Feifei / Huang, Fengming / Xu, Jun / Yang, Penghui / Qin, Yuhao / Lv, Jingjun / Zhang, Shaogeng / Ye, Lu / Gong, Ming / Liu, Zhibo / Wei, Jie / Xie, Tuxiu / Xu, Kai-Feng / Gao, George F. / Wang, Fu-Sheng / Cai, Lin / Jiang, Chengyu

    Cell Discov

    Abstract: ... to patients who took no drugs. The reduction of disease severity of elderly COVID-19 patients was associated ... Our data indicate that hypertension drugs ARB, ACEI, CCB, and BB might be beneficial for COVID-19 patients. ... statistically significantly improved in patients who took antihypertension drugs ARB, BB, and CCB after ...

    Abstract The novel coronavirus (CoV) severe acute respiratory syndrome (SARS)-CoV-2 outbreak began at the end of 2019 in Wuhan, China, and has spread to over 200 countries. In this multicenter retrospective study, we identified 2190 adult patients admitted for laboratory-confirmed COVID-19 in three participating centers. Multivariate logistic regression was conducted in patients with comorbid hypertension to examine the potential association between clinical outcomes, disease severity, and clinical characteristics with the use of ACEI, ARB, calcium-channel blockers (CCB), beta-blockers (BB), and thiazide diuretics. The clinical outcome, dyspnea, and fatigue were significantly improved in patients, especially elderly patients who were older than 65 years, who took ARB drugs prior to hospitalization compared to patients who took no drugs. The reduction of disease severity of elderly COVID-19 patients was associated with CCB and ACEI users. Clinical indices, including CRP, lymphocyte count, procalcitonin D dimer, and hemoglobin, were significantly improved in elderly ARB users. In addition, the clinical outcomes were statistically significantly improved in patients who took antihypertension drugs ARB, BB, and CCB after statistical adjustment by all ages, gender, baseline of blood pressures, and coexisting medical conditions. Our data indicate that hypertension drugs ARB, ACEI, CCB, and BB might be beneficial for COVID-19 patients.
    Keywords covid19
    Publisher PMC
    Document type Article ; Online
    DOI 10.1038/s41421-020-00221-6
    Database COVID19

    Kategorien

  4. Article ; Online: Antihypertensive drugs are associated with reduced fatal outcomes and improved clinical characteristics in elderly COVID-19 patients

    Feifei Yan / Fengming Huang / Jun Xu / Penghui Yang / Yuhao Qin / Jingjun Lv / Shaogeng Zhang / Lu Ye / Ming Gong / Zhibo Liu / Jie Wei / Tuxiu Xie / Kai-Feng Xu / George F. Gao / Fu-Sheng Wang / Lin Cai / Chengyu Jiang

    Cell Discovery, Vol 6, Iss 1, Pp 1-

    2020  Volume 10

    Abstract: ... to patients who took no drugs. The reduction of disease severity of elderly COVID-19 patients was associated ... Our data indicate that hypertension drugs ARB, ACEI, CCB, and BB might be beneficial for COVID-19 patients. ... statistically significantly improved in patients who took antihypertension drugs ARB, BB, and CCB after ...

    Abstract Abstract The novel coronavirus (CoV) severe acute respiratory syndrome (SARS)-CoV-2 outbreak began at the end of 2019 in Wuhan, China, and has spread to over 200 countries. In this multicenter retrospective study, we identified 2190 adult patients admitted for laboratory-confirmed COVID-19 in three participating centers. Multivariate logistic regression was conducted in patients with comorbid hypertension to examine the potential association between clinical outcomes, disease severity, and clinical characteristics with the use of ACEI, ARB, calcium-channel blockers (CCB), beta-blockers (BB), and thiazide diuretics. The clinical outcome, dyspnea, and fatigue were significantly improved in patients, especially elderly patients who were older than 65 years, who took ARB drugs prior to hospitalization compared to patients who took no drugs. The reduction of disease severity of elderly COVID-19 patients was associated with CCB and ACEI users. Clinical indices, including CRP, lymphocyte count, procalcitonin D dimer, and hemoglobin, were significantly improved in elderly ARB users. In addition, the clinical outcomes were statistically significantly improved in patients who took antihypertension drugs ARB, BB, and CCB after statistical adjustment by all ages, gender, baseline of blood pressures, and coexisting medical conditions. Our data indicate that hypertension drugs ARB, ACEI, CCB, and BB might be beneficial for COVID-19 patients.
    Keywords Cytology ; QH573-671 ; covid19
    Subject code 610 ; 616
    Language English
    Publishing date 2020-10-01T00:00:00Z
    Publisher Nature Publishing Group
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top